Covered recipient · General Payments record
NANCY LAMB
Allopathic & Osteopathic Physicians Psychiatry & Neurology Sleep Medicine
General Payments · PY2018–2024
$3,470.77
- Reported across 152 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $753.07 | 32 |
| Education | $21.04 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $132.89 | 7 |
| ABBVIE INC. | $122.54 | 5 |
| PFIZER INC. | $82.53 | 3 |
| ARGENX US, INC. | $78.56 | 3 |
| REVANCE THERAPEUTICS, INC. | $71.26 | 3 |
| HARMONY BIOSCIENCES LLC | $59.55 | 3 |
| Lilly USA, LLC | $59.47 | 3 |
| Abbott Laboratories | $49.59 | 2 |
| CSL Behring | $41.93 | 2 |
| SK Life Science, Inc. | $32.93 | 1 |
| Lundbeck LLC | $27.16 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $26.69 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124989521 | CMS |
| Abbott Laboratories | $22.90 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124989525 | CMS |
| ABBVIE INC. | $25.99 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104132168 | CMS |
| ABBVIE INC. | $33.18 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104132170 | CMS |
| ABBVIE INC. | $28.10 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104132172 | CMS |
| ABBVIE INC. | $21.50 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104132174 | CMS |
| ABBVIE INC. | $13.77 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104132176 | CMS |
| Amgen Inc. | $31.49 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115847113 | CMS |
| Amgen Inc. | $10.52 | 04/08/2024 | Education | Undisputed | 01/23/2026 | 1115847130 | CMS |
| Amgen Inc. | $27.56 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115847121 | CMS |
| Amgen Inc. | $25.79 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115847138 | CMS |
| Amgen Inc. | $10.52 | 06/24/2024 | Education | Undisputed | 01/23/2026 | 1115847147 | CMS |
| Amgen Inc. | $4.69 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115847155 | CMS |
| Amgen Inc. | $22.32 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115847163 | CMS |
| ARGENX US, INC. | $23.94 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142102548 | CMS |
| ARGENX US, INC. | $25.12 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142106221 | CMS |
| ARGENX US, INC. | $29.50 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142123651 | CMS |
| CSL Behring | $21.17 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134636221 | CMS |
| CSL Behring | $20.76 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134636239 | CMS |
| Harmony Biosciences Llc | $9.23 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141473142 | CMS |
| HARMONY BIOSCIENCES LLC | $24.87 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126057511 | CMS |
| HARMONY BIOSCIENCES LLC | $25.45 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126057509 | CMS |
| Lilly USA, LLC | $20.79 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135263789 | CMS |
| Lilly USA, LLC | $17.45 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135268096 | CMS |
| Lilly USA, LLC | $21.23 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135263793 | CMS |
| Lundbeck LLC | $27.16 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145937536 | CMS |
| PFIZER INC. | $24.80 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130889253 | CMS |
| PFIZER INC. | $28.44 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131019799 | CMS |
| PFIZER INC. | $29.29 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131094419 | CMS |
| REVANCE THERAPEUTICS, INC. | $21.79 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147922438 | CMS |
| REVANCE THERAPEUTICS, INC. | $23.43 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147922440 | CMS |
| REVANCE THERAPEUTICS, INC. | $26.04 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147922442 | CMS |
| SK Life Science, Inc. | $32.93 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154125922 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.70 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137612756 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.